Tag: EJVES

Latest meta-analysis on paclitaxel in peripheral arterial disease provokes mixed reception

“There appears to be heightened risk of major amputation after use of paclitaxel-coated balloons in the peripheral arteries,” findings from a systematic review...

Physicians call for clinical application of “helpful, meaningful” AMPREDICT decision support...

Researchers have found that the AMPREDICT decision support tool (DST) demonstrates “strong usability characteristics and clinical relevance” in amputation level decision-making for patients with...

Meta-analysis suggests screening elective vascular surgery patients for cognitive impairment “may...

Among individuals with “significant vascular surgical pathology,” John Houghton (University of Leicester, Leicester, UK) and colleagues have found that the prevalence of cognitive impairment...

High level of heterogeneity found in randomised PAD trial antithrombotic regimens

A recent systematic review showed that randomised trials comparing different types of peripheral endovascular arterial intervention have a high level of heterogeneity in their...

Collaborative efforts seek to understand COVID-19 impact on vascular patients

Amidst the continuing COVID-19 pandemic, concerns have mounted in the vascular community about the disruption to clinical routine. As vascular patients are particularly vulnerable...

Regional anaesthesia alone is reasonable for major lower extremity amputation in...

A recent study, published online on 3 August in the European Journal of Vascular and Endovascular Surgery (EJVES), found that regional anaesthesia alone is...

EJVES impact factor increase: Behind the success and looking ahead

When the 2019 journal impact factors were published earlier this summer, the European Journal of Vascular and Endovascular Surgery (EJVES) scored 5.328, an increase...